Cargando…

Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial

Objective: Toll-like receptor-3 agonist Poly-ICLC has been known to activate immune cells and induce HIV replication in pre-clinical experiments. In this study we investigated if Poly-ICLC could be used for disrupting HIV latency while simultaneously enhancing innate immune responses. Design: This w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saxena, Mansi, Sabado, Rachel L., La Mar, Melissa, Mohri, Hiroshi, Salazar, Andres M., Dong, Hanqing, Correa Da Rosa, Joel, Markowitz, Martin, Bhardwaj, Nina, Miller, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467168/ https://www.ncbi.nlm.nih.gov/pubmed/31024557 http://dx.doi.org/10.3389/fimmu.2019.00725

Ejemplares similares

Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas
por: Okada, Hideho, et al.
Publicado: (2013)

PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo
por: Aravantinou, Meropi, et al.
Publicado: (2016)

Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis
por: Sionov, Edward, et al.
Publicado: (2015)

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
por: Mehrotra, Shikhar, et al.
Publicado: (2017)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
por: Melssen, Marit M., et al.
Publicado: (2019)

A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
por: De Waele, Jorrit, et al.
Publicado: (2021)

A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
por: Vagenas, Panagiotis, et al.
Publicado: (2010)

Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events
por: Voges, Alessandra Rinah Nogueira, et al.
Publicado: (2021)

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers
por: Caskey, M, et al.
Publicado: (2012)

Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
por: Barnard, Dale L., et al.
Publicado: (2011)

Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol(®) (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model
por: Kumaki, Yohichi, et al.
Publicado: (2017)

IFN-γ- and IL-17-producing CD8(+) T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity
por: Ohkuri, Takayuki, et al.
Publicado: (2021)

Epicardium: interstitial Cajal-like cells (ICLC) highlighted by immunofluorescence
por: Suciu, L, et al.
Publicado: (2009)

Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients
por: Boydell, Emma, et al.
Publicado: (2019)

Modulation of Innate Immune Responses via Covalently Linked TLR Agonists
por: Tom, Janine K., et al.
Publicado: (2015)

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023)

Insights into the interstitium of ventricular myocardium: interstitial Cajal-like cells (ICLC)
por: Popescu, LM, et al.
Publicado: (2006)

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
por: Zhu, Xinmei, et al.
Publicado: (2007)

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
por: Liu, Hongtao, et al.
Publicado: (2018)

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer
por: Dillon, Patrick M., et al.
Publicado: (2017)

Stimulation of Innate Immune Cells by Light-Activated TLR7/8 Agonists
por: Ryu, Keun Ah, et al.
Publicado: (2014)

Interstitial Cajal-like cells (ICLC) in atrial myocardium: ultrastructural and immunohistochemical characterization
por: Hinescu, M E, et al.
Publicado: (2006)

Myocardial interstitial Cajal-like cells (ICLC) in caveolin-1 KO mice
por: Gherghiceanu, M, et al.
Publicado: (2009)

A distinct type of cell in myocardium: interstitial Cajal-like cells (ICLCs)
por: Kostin, S, et al.
Publicado: (2009)

Interstitial Cajal-like cells (ICLC) in myocardial sleeves of human pulmonary veins
por: Gherghiceanu, Mihaela, et al.
Publicado: (2008)

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)
por: Slingluff, Jr., Craig L, et al.
Publicado: (2021)

TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
por: Mifsud, Edin J., et al.
Publicado: (2014)

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
por: Temizoz, Burcu, et al.
Publicado: (2015)

Innate Immune Receptors in Human Airway Smooth Muscle Cells: Activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 Agonists
por: Månsson Kvarnhammar, Anne, et al.
Publicado: (2013)

Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist
por: Ryu, Keun Ah, et al.
Publicado: (2017)

Interstitial Cajal-like cells (ICLC) as steroid hormone sensors in human myometrium: immunocytochemical approach
por: Cretoiu, D, et al.
Publicado: (2006)

TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair
por: Natarajan, Chandramohan, et al.
Publicado: (2016)

TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
por: Komal, Asma, et al.
Publicado: (2021)

Myocardial interstitial Cajal-like cells (ICLC) and their nanostructural relationships with intercalated discs: shed vesicles as intermediates
por: Mandache, E, et al.
Publicado: (2007)

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
por: Dold, L., et al.
Publicado: (2020)

Eicosanoids in the Innate Immune Response: TLR and Non-TLR Routes
por: Alvarez, Yolanda, et al.
Publicado: (2010)

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
por: Tamir, Hadas, et al.
Publicado: (2022)

A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection
por: Hedges, Jodi F., et al.
Publicado: (2023)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

Innate Immune Response to Streptococcus pyogenes Depends on the Combined Activation of TLR13 and TLR2
por: Fieber, Christina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_thunjvced3p4054inib605ga3k